As of February 2026 ImmunityBio has a market cap of A$13.53 Billion. This makes ImmunityBio the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 27th, 2026 the market cap of ImmunityBio was reported to be: